← brief for 2026-08-14 · Slowing decline

Serum galectin-3 as a biomarker of metabolic syndrome, cardiovascular risk, and total mortality

Paper B Peer reviewed Small trial

Key takeaways

This study found that high galectin-3 levels correlate with cardiovascular risk and death. The group was large: 1,000 patients, 5-year follow-up.

Who did this work

Yasmina Filali (Oulu University Hospital) · Eija Pirinen (University of Helsinki) · Päivi Lempiäinen (Oulu University Hospital) · A. Ylitalo (University of Turku) · Heikki V. Huikuri (Oulu University Hospital) · Joona Tapio (University of Oulu) · Olavi Ukkola (Oulu University Hospital)

Source

Paper · OpenAlex, CKD works · 2026-08-12
https://doi.org/10.1038/s41598-026-64864-3